HA-high Has2ΔNeo and HA-low Has2+Neo cancer cells were treated with cisplatin, a platinum-based chemotherapeutic drug, and the numbers of early and late apoptotic cells were determined by dual staining with fluorescent Annexin V and propidium iodide (PI). The gene discussed is HAS2; the disease is cancer.